Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 576-600 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
In patients with COVID-19 in its recovery period.
Design:
A clinical trial with a control group (...) :
Patients aged 35-55 years old who have a history of hospitalization due to COVID-19 virus. A minimum of 1
Study aim:
purpose of this study is to Determine the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19.
Design:
clinical trial with control group, with parallel groups (...) hospital.
Participants/Inclusion and exclusion criteria:
1. Patients who test positive for COVID-19 by a
with COVID-19 pneumonia
Design:
Parallel double blind randomized clinical trial study
Settings and conduct:
The umbilical cord will be provided by volunteer donors at Fatemieh Hospital. Patients with COVID19 with acute respiratory distress who have been admitted to the intensive care unit of Sinai
Study aim:
Treatment and reduction of the course of treatment of patients with Covid-19
Design (...) : People with COVID-19. Exclusion criteria: none.
Intervention groups:
The first group (A): the group (...) contact with a person with covid19 over the past two weeks
Oral fever with more than 38 degrees Celsius
parameters and regulating coagulation factors in patients with covid-19
Design:
The study is a phase-3 randomized double-blind clinical trial, in which people with covid-19 will be divided into two groups with 30 (...) phase-3 double-blind clinical trial. People with covid-19 who will refer to the Prophet's hospital will
recovery trend in Patients with Known COVID-19
Design:
Randomized clinical trial with parallel group trial, double-blinded ,first phase carried out on 40 Covid-19 patients. Randomization was carried out with rand (...) exclusion criteria:
Patients with Known COVID-19
Intervention groups:
1. Receiving boron containing
Study aim:
Studying the therapeutic effect and side effects of dexamethasone in COVID-19 positive patients with mild to moderate symptoms
Design:
Clinical trial with parallel randomized groups
Settings (...)
Participants/Inclusion and exclusion criteria:
In this study, 18 year old patients with confirmed COVID-19
Study aim:
Determination of the effect of curcumin-piperine supplementation on disease duration, severity, and clinical signs and inflammatory factors in patients with coronavirus (COVID-19): A randomized (...) years; Diagnosis of Covid-19 based on the PCR test.
Exclusion criteria: Age less than 20 and more than
Study aim:
determination of the efficiency and safety of favipiravir+hydroxychloroquine in comparison with hydroxychloroquine in hospitalized patients with covid-19
Design:
Clinical trial with (...) exclusion criteria:
Inpatients with COVID-19 in Shahid Modarres Hospital who have the conditions to enter
Study aim:
The effect of H.pseudoplicatum-syrup on clinical presentation and respiratory infection of patients with COVID-19
Design:
This study is a clinical trial. In this study, there are two (...) : "Having informed consent to participate in the study, definitive diagnosis of COVID-19 and not attending
COVID-19 patients based on a 9-points WHO ordinal scale
Design:
Clinical trial with control group, with (...) performed on 86 patients with COVID-19 in two intervention and control groups. Patients are treated (...) :
Hospitalized patients with confirmed COVID-19 will be included in this study if they fulfilled two primary
Study aim:
Evaluation of clinical and laboratory effect of ANIF1 new antiviral drug in COVID-19 patients
Design:
Clinical trial, double blind, with control group, randomized.patients and docters dont know about which group they are ,drug and placebo,.an accidental tabale number use to decrese the bias
Study aim:
The effect of naproxen on the healing process of COVID-19 patients
Design:
This double (...) :
Inclusion criteria: COVID-19 patients that have positive PCR test of nasopharyngeal sample or have positive (...) with Covid19 (improvement of fever, chills, cough and night sweats)
Study aim:
Evaluation of the efficacy of Ipecac homeopathy remedy in controlling covid-19 disease symptoms and accelerating the recovery process
Design:
A randomized, controlled, double-blind, placebo (...) diagnosis of Covid-19(according to national guideline).
Definition of Covid-19 Suspected Case:
A. Patient
Study aim:
The comparison of the clinical outcomes of patients with COVID -19 consuming renin-angiotensin-aldosterone system inhibitors with ceasing their consumption for whom calcium channel blockers (...) :
Inclusion criteria: Patients who have suggestive signs of COVID-19 in their chest computed tomography scan
Study aim:
Evaluation the efficacy of Anti- TNF on COVID-19
Design:
In this simple clinical trial study, 80 patients with inclusion criteria will be selected by the non-randomized selection and divided (...) exclusion criteria:
Confirmed the COVID-19 disease with one or more of these: fever, dry cough, dyspnea and
Study aim:
To determine the effect of intratracheal injection of processed autologous serum derived from patients with COVID-19 in oxygenation parameters and pulmonary complications
Design:
Randomised (...) a 22-bed ICU in northwest of Iran. Intubated patients with COVID-19 under mechanical ventilation
patients with Covid-19
Design:
Open label phase 3 clinical trial with a control group and parallel groups (...) conduct:
This study will be performed on patients with Covid19 in Firoozgar Hospital in Tehran and the (...) , definitive diagnosis of Covid19 and having informed consent. Also, exclusion criteria included allergies to
Study aim:
Evaluation of the effect of oxygen-rich water as an adjunct to supportive therapy in improving the clinical condition of patients with Covid19
Design:
From the case of Patients with Covid19(...) water used.
Participants/Inclusion and exclusion criteria:
Inclution Criteria:
Patients with Covid19
vitro culture in patients with COVID-19 related acute respiratory distress syndrome
Design:
The study is a single arm, non randomized, non-blinded Phase 1 clinical trial in 10 patients with COVID-19(...) > 50 mmHg or history of oxygen consumption at home
Intervention groups:
Patients with COVID-19-induced
experiencing persistent Anosmia following COVID-19 infection.
Design:
A parallel-group, single-blind (...) sense of smell in the last month following a COVID-19 infection.
Participants/Inclusion and exclusion criteria:
Patients with a confirmed diagnosis of COVID-19 in the past, who self-report experiencing
gastrointestinal symptoms in patients with COVID-19
Design:
Clinical trial with control group, parallel group (...) in the control group). Replacement randomization was used.
Settings and conduct:
COVID-19 positive (...) criteria:
Patients with COVID-19 positive rapid test or RT-PCR; aged 18 to 70 years with gastrointestinal
, blue-green algae) and N-acetyl cysteine in patients with COVID-19 infection
Design:
This randomized (...) patients who will be randomly selected using the blocks.
Settings and conduct:
Patients with COVID-19(...) exclusion criteria:
Inclusion criteria: Patients with COVID-19 infection base on clinical manifestations
from covid-19
Design:
Before starting the interventions, all independent and dependent variables (...) Hospital.
Participants/Inclusion and exclusion criteria:
A definite diagnosis of covid-19 and discharge from the hospital
over 18
has not suffered from any other acute illness except for covid-19 in the